J&J brings forward start of COVID-19 vaccine trial to next month

Johnson & Johnson has announced it has brought forward the start of its COVID-19 vaccine by around two months to mid-July.

The company’s Janssen drugs unit is developing a vaccine, Ad26.COV2-S recombinant, against the SARS-CoV-2 coronavirus that causes the disease and had originally planned to begin clinical development in September.